Exenatide Injection: Clinical Trials

2 trials of Exenatide Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1

Follow Exenatide Injection: new trials by email Literature Review of Exenatide Injection trials Research Report on Exenatide Injection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of EXenatide in Acute Ischaemic Stroke
Exenatide Injection - Acute Ischemic Stroke
Phase 2UnknownNeuroscience Trials Australia3502017-11-232021-09-14
Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
ITCA 650, Exenatide Injection, Ex Inj/ITCA 650 - Type 2 Diabetes
Phase 2CompletedIntarcia Therapeutics1552009-08-012015-04-13

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Ischemic Stroke (1)  ·  Stroke (1)

Sponsors

Intarcia Therapeutics (1)  ·  Neuroscience Trials Australia (1)

Countries

Australia (1)  ·  Finland (1)  ·  New Zealand (1)  ·  United States (1)

Top investigators

Christopher Bladin (1)

Results publications

PMID 23645886, PMID 38011235

NIH funding

2018 (1)